In December our Patient Advocacy team attended the American Society of Hematology (ASH) 2019 meeting in Florida, along with our trustee Dr Manos Nikolousis.
In this video, he describes how, thanks to increasing use of genetic and molecular information, newer non-chemotherapy medicines are changing the treatment of acute myeloid leukaemia (AML). youtu.be/dEQyvbOqISE
Written by
HAIRBEAR_UK
To view profiles and participate in discussions please or .
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.